Exact Sciences Corporation (BMV:EXAS)
Mexico
· Delayed Price · Currency is MXN 890.12
-159.88 (-15.23%)
At close: Jul 29, 2025
Exact Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,247 | 2,759 | 2,500 | 2,084 | 1,767 | Upgrade
|
| Revenue Growth (YoY) | 17.69% | 10.37% | 19.93% | 17.95% | 18.49% | Upgrade
|
| Cost of Revenue | 984.15 | 840.15 | 737.56 | 661.36 | 458.76 | Upgrade
|
| Gross Profit | 2,263 | 1,919 | 1,762 | 1,423 | 1,308 | Upgrade
|
| Selling, General & Admin | 1,891 | 1,679 | 1,646 | 1,650 | 1,538 | Upgrade
|
| Research & Development | 522.44 | 431.21 | 426.93 | 394.19 | 385.65 | Upgrade
|
| Amortization of Goodwill & Intangibles | - | - | - | - | 95 | Upgrade
|
| Other Operating Expenses | - | - | -2.03 | 13.24 | - | Upgrade
|
| Operating Expenses | 2,413 | 2,111 | 2,071 | 2,057 | 2,019 | Upgrade
|
| Operating Income | -150.12 | -191.79 | -308.84 | -634.16 | -710.57 | Upgrade
|
| Interest Expense | -39.36 | -37.27 | -19.45 | -19.63 | -18.61 | Upgrade
|
| Interest & Investment Income | 41.77 | 39.56 | 32.71 | - | 31.78 | Upgrade
|
| EBT Excluding Unusual Items | -147.71 | -189.5 | -295.57 | -653.79 | -697.4 | Upgrade
|
| Merger & Restructuring Charges | -22.17 | - | - | - | -117.7 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -19.43 | - | Upgrade
|
| Asset Writedown | -7.2 | -869.46 | -0.62 | -15.97 | -20.21 | Upgrade
|
| Other Unusual Items | -26.81 | 22.8 | 94.44 | 56.62 | -7.2 | Upgrade
|
| Pretax Income | -203.89 | -1,036 | -201.75 | -632.57 | -842.51 | Upgrade
|
| Income Tax Expense | 4.06 | -7.3 | 2.4 | -9.06 | -246.88 | Upgrade
|
| Net Income | -207.95 | -1,029 | -204.15 | -623.51 | -595.63 | Upgrade
|
| Net Income to Common | -207.95 | -1,029 | -204.15 | -623.51 | -595.63 | Upgrade
|
| Shares Outstanding (Basic) | 189 | 184 | 180 | 176 | 171 | Upgrade
|
| Shares Outstanding (Diluted) | 189 | 184 | 180 | 176 | 171 | Upgrade
|
| Shares Change (YoY) | 2.44% | 2.25% | 2.15% | 2.92% | 13.37% | Upgrade
|
| EPS (Basic) | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 | Upgrade
|
| EPS (Diluted) | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 | Upgrade
|
| Free Cash Flow | 356.78 | 74.55 | 31.93 | -438.02 | -238 | Upgrade
|
| Free Cash Flow Per Share | 1.89 | 0.41 | 0.18 | -2.48 | -1.39 | Upgrade
|
| Gross Margin | 69.69% | 69.55% | 70.49% | 68.27% | 74.04% | Upgrade
|
| Operating Margin | -4.62% | -6.95% | -12.35% | -30.43% | -40.21% | Upgrade
|
| Profit Margin | -6.40% | -37.29% | -8.17% | -29.92% | -33.71% | Upgrade
|
| Free Cash Flow Margin | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% | Upgrade
|
| EBITDA | 71.46 | 23.07 | -102.23 | -436.6 | -530.22 | Upgrade
|
| EBITDA Margin | 2.20% | 0.84% | -4.09% | -20.95% | -30.00% | Upgrade
|
| D&A For EBITDA | 221.58 | 214.86 | 206.61 | 197.56 | 180.35 | Upgrade
|
| EBIT | -150.12 | -191.79 | -308.84 | -634.16 | -710.57 | Upgrade
|
| EBIT Margin | -4.62% | -6.95% | -12.35% | -30.43% | -40.21% | Upgrade
|
| Advertising Expenses | 199.2 | 180.3 | 137.9 | 170.3 | 144 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.